globenewswire.com

Reputation Factor: 3.23 High
Sites Owned: 3
Total Reference Links: 129
Total Citations: 142
Unique Wikipedia Articles Citing: 131

Associated Sites

globenewswire.com

Uncategorized

Links: 1

Citations: 1

ml-eu.globenewswire.com

Uncategorized

Links: 3

Citations: 3

www.globenewswire.com

News

Links: 125

Citations: 138

Top Reference Links

Score	Article	Site	Category	Cited In (Articles)
9.7	Galle Gallants begin new chapter in Lanka Premier League https://www.globenewswire.com/news-release/2026/05/04/3286576/0/en/galle-gallants-announce-new-ownership-under-gallant-sports-and-media-llc-within-urban-gro-flash-sports-media-ipg-operated-lpl-season-6-ecosystem-pubudu-dassanayake-appointed-head-c.html	www.globenewswire.com	News	3
6.5	Chips&Media Completes Development of Next-Gen 'AV2' HW Decoder IP, Accelerating Global Market Leadership https://www.globenewswire.com/news-release/2026/06/10/3309684/0/en/Chips-Media-Completes-Development-of-Next-Gen-AV2-HW-Decoder-IP-Accelerating-Global-Market-Leadership.html	www.globenewswire.com	News	2
6.5	Crinetics Announces FDA Approval of Palsonify (paltusotine) for the Treatment of Adults with Acromegaly https://www.globenewswire.com/news-release/2025/09/25/3156767/0/en/Crinetics-Announces-FDA-Approval-of-PALSONIFY-paltusotine-for-the-Treatment-of-Adults-with-Acromegaly.html	www.globenewswire.com	News	2
6.5	Citi(R) Presents A Very Special Performance from Coldplay at the Beacon Theatre https://www.globenewswire.com/en/news-release/2014/04/24/1002696/0/en/Citi-R-Presents-a-Very-Special-Performance-From-Coldplay-at-the-Beacon-Theatre.html	www.globenewswire.com	News	2
6.5	PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01 https://www.globenewswire.com/news-release/2026/04/27/3281580/0/en/PharmAla-Executes-Binding-Letter-of-Intent-for-Formation-of-Special-Purpose-Vehicle-to-Develop-Patented-Novel-MDXX-Molecule-APA-01.html	www.globenewswire.com	News	2
6.5	U.S. FDA grants accelerated approval to Boehringer's Hernexeos as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC https://www.globenewswire.com/news-release/2025/08/08/3130334/0/en/U-S-FDA-grants-accelerated-approval-to-Boehringer-s-HERNEXEOS-as-first-orally-administered-targeted-therapy-for-previously-treated-patients-with-HER2-mutant-advanced-NSCLC.html	www.globenewswire.com	News	2
3.2	MazeBolt Appoints Tan Parker to Its Board of Directors https://www.globenewswire.com/news-release/2026/07/22/3331652/0/en/MazeBolt-Appoints-Tan-Parker-to-Its-Board-of-Directors.html	www.globenewswire.com	News	1
3.2	Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk https://www.globenewswire.com/news-release/2025/07/29/3123141/0/en/Maziar-Mike-Doustdar-appointed-as-president-and-chief-executive-officer-of-Novo-Nordisk.html	www.globenewswire.com	News	1
3.2	Trupeer.ai Raises $3M to Unlock Studio Quality Videos for Every Software https://www.globenewswire.com/news-release/2025/07/15/3115642/0/en/Trupeer-ai-Raises-3M-to-Unlock-Studio-Quality-Videos-for-Every-Software.html	www.globenewswire.com	News	1
3.2	Nano Dimension Announces Closing of Markforged Acquisition https://www.globenewswire.com/news-release/2025/04/25/3068305/0/en/Nano-Dimension-Announces-Closing-of-Markforged-Acquisition.html	www.globenewswire.com	News	1

Citation Trends Over Time